1. Home
  2. BAND vs VNDA Comparison

BAND vs VNDA Comparison

Compare BAND & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bandwidth Inc.

BAND

Bandwidth Inc.

HOLD

Current Price

$20.42

Market Cap

395.6M

Sector

Technology

ML Signal

HOLD

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

HOLD

Current Price

$7.16

Market Cap

474.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BAND
VNDA
Founded
2000
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
395.6M
474.0M
IPO Year
2017
2005

Fundamental Metrics

Financial Performance
Metric
BAND
VNDA
Price
$20.42
$7.16
Analyst Decision
Buy
Strong Buy
Analyst Count
5
5
Target Price
$20.40
$14.90
AVG Volume (30 Days)
359.0K
1.5M
Earning Date
04-30-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$204,113,000.00
$216,105,000.00
Revenue This Year
$15.16
$21.35
Revenue Next Year
$6.18
$37.40
P/E Ratio
N/A
N/A
Revenue Growth
25.26
8.72
52 Week Low
$11.33
$3.81
52 Week High
$19.59
$9.91

Technical Indicators

Market Signals
Indicator
BAND
VNDA
Relative Strength Index (RSI) 71.36 45.16
Support Level $13.20 $7.12
Resistance Level N/A $8.29
Average True Range (ATR) 1.04 0.32
MACD 0.14 0.02
Stochastic Oscillator 97.77 47.13

Price Performance

Historical Comparison
BAND
VNDA

About BAND Bandwidth Inc.

Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to enterprise customers. The majority of the company's revenue is generated from usage-based fees that includes voice communication and messaging communication that traverse the platform and network.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: